39 results
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
TAKHZYRO, with continued investment in lifecycle management programs. In rare hematology, Takeda focuses on addressing today’s needs in the treatment
6-K
TAK
Takeda Pharmaceutical Co
30 Oct 23
Current report (foreign)
6:02am
, including through TAKHZYRO, with continued investment in lifecycle management programs. In rare hematology, Takeda focuses on addressing today’s needs
6-K
TAK
Takeda Pharmaceutical Co
1 Aug 23
Current report (foreign)
6:10am
, Takeda aspires to transform the treatment paradigm, including through TAKHZYRO, with continued investment in lifecycle management programs. In rare
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
from the start. This program works to embed sustainability considerations into our decision-making for all aspects of a product’s lifecycle. It also … framework, we are integrating processes and building strategies to minimize lifecycle environmental impacts of our products, including supporting our net
6-K
EX-99.1
moh5e
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
22s772u2
30 May 23
Current report (foreign)
6:11am
6-K
9h3 d31md
4 Nov 22
Current report (foreign)
6:01am
6-K
rlc40prgo4ksrg f1tzv
4 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
oaq2fdn760q y7
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
51e1dlh595zo4s
31 May 22
Current report (foreign)
6:07am
6-K
7s36i7qbfuiodo
11 May 22
Current report (foreign)
6:06am
6-K
ul2y6n
10 Feb 22
Current report (foreign)
6:03am
6-K
EX-99.1
ig1cztr2w7
11 Jan 22
Current report (foreign)
6:02am
6-K
htcr8uw869k obfliqt
5 Nov 21
Current report (foreign)
6:02am
6-K
bvyzpxzv7ripsyf59 fo
6 Aug 21
Current report (foreign)
6:06am
6-K
EX-99.1
vpbha8pgzqf
29 Jun 21
Current report (foreign)
7:38am
6-K
EX-99.1
itkubxw9i5 he
28 May 21
Current report (foreign)
6:01am